BFIM
IDXX icon

Beese Fulmer Investment Management’s Idexx Laboratories IDXX Stock Holding History

Beese Fulmer Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-510
Closed -$287K – 453
2026
Q1 		$287K Buy
510
+170
+50% +$109K 0.02% 320
2025
Q4 		$230K Buy
+340
New +$232K 0.02% 355

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Beese Fulmer Investment Management's IDXX Position: Q2 2026 in Review

Beese Fulmer Investment Management sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 510 shares — an estimated $287K sold.

Beese Fulmer Investment Management first reported a position in IDXX in Q4 2025 and held it in 2 quarters. The position peaked at $287K in Q1 2026. 936 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Beese Fulmer Investment Management reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Beese Fulmer Investment Management sold 510 Idexx Laboratories shares in Q2 2026, an estimated $287K.
  • Beese Fulmer Investment Management first reported a position in Idexx Laboratories in Q4 2025 and held it in 2 quarters.
  • Beese Fulmer Investment Management's Idexx Laboratories position peaked at $287K in Q1 2026.
  • 936 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Beese Fulmer Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.